// App-Quantinova.ai

4641 : Use of Intravenous Immune Globulin in Patients with Immune Thrombocytopenia Before and After Romiplostim: Real-World Experience

Researchers

Presenter

  • Lisa J. Toltl

Principal Investigators

  • Grace Wang

  • Donald M. Arnold

  • Naushin S Sholapur

  • Julie Carruthers

  • Cyrus C. Hsia

  • Caroline Hamm

  • Normand Blais

  • Catherine Girard-Desbiens

  • Marc-Andre Pearson

  • Nancy Heddle

Medical Centers

  • Hematology-Oncology, CHUM, Montreal, QC, Canada

  • CRCHUM, Montreal, QC, Canada

  • Hematology-Oncology, CHUM-Hopital Notre-Dame, Montreal, QC, Canada,

  • McMaster University, Hamilton, ON, Canada

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

  • McMaster University, Hamilton, ON, Canada

  • Health Research Methodology, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada, Hamilton, ON, Canada

  • Medicine, Division of Hematology, University of Western Ontario, London Health Sciences - Victoria Hospital, London, ON, Canada

  • Dept. of Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, Windsor, Windsor, ON, Canada

  • McMaster University, Hamilton, ON, Canada, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Immune thrombocytopenia

  • Intracerebral hemorrhage

  • Thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • Immune globulin

  • Romiplostim

  • IVIG

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim